Federal award
APTIMA INC
W911NF19F0030
ContractSBIR/STTR SR3
Obligated and Ceiling
- Obligated (net)
- $348,521.00
- Ceiling (potential value, not spending)
- $348,521.00
- Current value
- $348,521.00
- Gross positive obligations
- $349,988.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- APTIMA INC · K1GCPNNZKEN7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- APTIMA, INC. · FJQDBZL3FTW3
- Awarding agency
- Department of War · sub-agency 2100 · office W911NF
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- AJ63 · R&D- GENERAL SCIENCE/TECHNOLOGY: PSYCHOLOGICAL SCIENCES (ADVANCED DEVELOPMENT)
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- W911NF19F0030
- Parent vehicle (IDV PIID)
- W911NF18D0003
- Award type code
- C
- Actions
- 8 · Aug 15, 2019 to Nov 20, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History8
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Nov 20, 2024 | FY2025 | P00005 | C | −$1,467.00 | — |
| Jan 25, 2024 | FY2024 | ARZ998 | B | $0.00 | — |
| Jan 22, 2024 | FY2024 | ARZ999 | B | $0.00 | — |
| Aug 12, 2022 | FY2022 | P00004 | D | $0.00 | — |
| Dec 6, 2021 | FY2022 | P00003 | D | $0.00 | — |
| Jun 8, 2021 | FY2021 | P00002 | M | $0.00 | — |
| Dec 2, 2019 | FY2020 | P00001 | C | $180,977.00 | — |
| Aug 15, 2019 | FY2019 | 0 | — | $169,011.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.